New MIMS table to guide antihypertensive monitoring in primary care

Monitoring requirements for ACE inhibitors and angiotensin II antagonists are summarised in a new MIMS table.

by Chloe Harman
Monitoring required for patients on ACE inhibitors or angiotensin II antagonists includes renal function and electrolytes. | GETTY IMAGES
Monitoring required for patients on ACE inhibitors or angiotensin II antagonists includes renal function and electrolytes. | GETTY IMAGES

Sign in to continue

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now

Subscribe now

Benefits include:

  • Full site access
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a package